Harnessing RNA nanomedicine for precision therapy in cancer and inflammation
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: PEER, Dan (Tel Aviv University Cancer Biology Research Center, Dept. of Cell Research & Immunology, and Dept. of Materials Science & Engineering, Tel Aviv, Israel)
- Co-author(s): Dan Peer: Dept. of Cell Research & Immunology, George S. Wise Faculty of life Sciences, Laboratory of Precision Nanomedicine, Tel Aviv, Israel;Dept. of Material Sciences and Engineering, Faculty of Engineering, Tel Aviv, Israel;The Center for Nanoscience & Nanotechnology, Tel Aviv, ;Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel
RNA based approaches have greatly contributed to better understanding of gene expression and function in vitro. The capability to apply these strategies in vivo in order to validate the role of specific genes in normal or pathological conditions, and to induce therapeutic gene silencing or upregulate a specific protein expression, opened new.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.